secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allogene Therapeutics, Inc. (ALLO)
CIK:        0001737287
Form:       8-K
Filed at:   2023-06-15T23:59:59+00:00
Accession:  0001737287-23-000063
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allogene Therapeutics shareholders elect four Class II directors, approve say-on-pay and auditor ratification
--------------------------------------------------------------------------------

- Deborah Messemer, Vicki Sato, Todd Sisitsky, and Owen Witte elected as Class II directors to serve until 2026.
- Advisory vote on named executive officer compensation passed with 73,082,912 for, 31,751,974 against, 1,939,920 abstentions.
- Ratification of Ernst & Young as independent auditor for FY2023 passed with 120,675,447 for, 36,870 against, 9,115 abstentions.
- Broker non-votes of 13,946,626 on director election and say-on-pay; no broker non-votes on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737287/000173728723000063/0001737287-23-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737287/000173728723000063/allo-20230613.htm
  HTML page:      https://secwatch.observer/filing/0001737287-23-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer